SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: betty moyers who wrote (11266)7/12/1998 12:12:00 PM
From: Mkilloran  Read Replies (1) of 23519
 
betty...Brazil and Argentina are also approved to sell Muse...

I agree it would help if Vivus updated it's web page and listed all of the countries that are approved for sales...and date of approval.

The key point is that most of the approved countries were not able to sell Muse in the 2nd qtr due to limited supply from the old plant...
The UK is the only one that was selling Muse for the enire 2nd qtr.

I would expect now that the new plant is producing Muse that the 3rd qtr will show good sales from all approved countries.

Now we need more large countries to be aproved asap and sales to be booked asap.

An a large partner in the USA to improve sales in the USA.

At the current price of VVUS stock I would think Astra and / or J&J
would be reviewing a possible equity position in Vivus. The R&D effort on drugs in the Vivus pipleline in addition to Muse has more value than the current stock price IMO.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext